EN
RU
Aliskiren (CAS: 173334-57-1) is a premium-grade pharmaceutical intermediate primarily utilized in the research, development, and synthesis of direct renin inhibitors for cardiovascular applications. As a highly purified chemical compound, it serves as a critical component in formulating active pharmaceutical ingredients (APIs) targeting essential hypertension. Manufactured under strict quality control protocols, our Aliskiren guarantees exceptional batch-to-batch consistency, optimal chemical stability, and high synthesis yield. This rigorous standard ensures reliable performance for both advanced academic biochemical research and large-scale commercial manufacturing processes.
Company Name :
Hangzhou GlobalEquipX Information Technology co.,Ltd .Brand :
APIsCNCAS Number :
173334-57-1
Product categoriesGlobalEquipX is a professional platform dedicated to the global pharmaceutical industry,
Backed by strong industry expertise, one of our co-founders serves as a strategic advisor to leading pharmaceutical manufacturers and R&D companies in China, including HEC and Menovo, giving us unique insight into market trends and client needs.
With numerous pharmaceutical manufacturers sites, we always ensure consistent quality and sustainable supply.
With over 30 years of proven experiences in import and export in EXP/IMP, we deliver flexible cooperation models and comprehensive one-stop solutions covering API & Intermediate, chemicals, and equipment—helping our clients streamline sourcing and accelerate business growth.
We do hope to have the chance to supply you our sustainable qualified service.
| 13183-79-4 | 5-Mercapto-1-Methyltetrazole | 864731-61-3 | Fluralaner | 68373-14-8 | Sulbactam acid |
| 173334-57-1 | Aliskiren | 54-31-9 | Furosemide | 76497-13-7 | Sultamicillin |
| 73547-70-3 | Ceftazidime dihydrochloride | 1369764-02-2 | Lemborexant | 89786-04-9 | Tazobactam acid |
| 113136-77-9 | Cyclanilide | 1138245-21-2 | Mirogabalin besylate | 2023788-19-2 | Tirzepatide |
| 211427-08-6 | Diquafosol tetrasodium | 186826-86-8 | Moxifloxacin hydrochloride | 1197-18-8 | Tranexamic acid |
| 1229194-11-9 | Edoxaban | 1192491-61-4 | NXL 104 | 2050057-56-0 | Upadacitinib |
| 1210344-83-4 | Ertugliflozin L-pyroglutamic acid | 144689-63-4 | Olmesartan Medoxomil | 1190389-15-1 | Vibegron |
| 1632006-28-0 | Esaxerenone | 93-10-7 | Quinaldic acid | 7078-98-0 |
2,6-bis(1,1-dimethylethyl)-4- (phenylmethylene)-2, 5-cyclohexadien-1-one |
| Biocatalysis | |||||
Aliskiren (CAS: 173334-57-1) is a premium-grade pharmaceutical intermediate primarily utilized in the research, development, and synthesis of direct renin inhibitors for cardiovascular applications. As a highly purified chemical compound, it serves as a critical component in formulating active pharmaceutical ingredients (APIs) targeting essential hypertension. Manufactured under strict quality control protocols, our Aliskiren guarantees exceptional batch-to-batch consistency, optimal chemical stability, and high synthesis yield. This rigorous standard ensures reliable performance for both advanced academic biochemical research and large-scale commercial manufacturing processes.
Our hours
Public Account
IPv6 network supported
Technical Articles
